Sequential Seasonal H1N1 Influenza Virus Infections Protect Ferrets against Novel 2009 H1N1 Influenza Virus

2009 H1N1 Influenza Virus Seroepidemiology

2009 h1n1 influenza virus seroepidemiology

0

High Titers of Hemagglutination Inhibition Antibodies against 2009 H1N1 Influenza Virus in Southern Iran

Background: Pandemic flu had at least two waves in Iran. Knowing how many of the general population were already exposed to this infection has a major impact on na-tional preventive measures. As of December 30, 2009, a total of 3672 confirmed cases of human infection with a novel Influenza A (2009 H1N1) virus had been reported in Iran with 140 deaths. Objective: In this study we aim to measure,...

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir

The main antivirals employed to combat seasonal and pandemic influenza are oseltamivir and zanamivir which act by inhibiting the virus-encoded neuraminidase. These have to be deployed close to the time of infection and antiviral resistance to the more widely used oseltamivir has arisen relatively rapidly. Defective interfering (DI) influenza virus is a natural antiviral that works in a differen...

2009 H1N1 influenza virus and immunosuppressive drug.

1. Centers for Diseases Control and Prevention. Updated interim recommendations: special considerations for clinicians regarding 2009 H1N1 influenza in severely immunosuppresed patients (on line). [Acessed on 2010 Sept 13]. Available from: http://www.cdc.gov/h1n1flu/immunosuppresion/ 2. Bacal F, Seguro LF, Ogawa T, Mangini S, Fiorelli AI, Bocchi E. Pneumonia por influenza A (H1N1) em paciente i...